Beyond analysts' top -and-bottom-line estimates for CrowdStrike (CRWD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended April 2025.

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Guidewire Software (GWRE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.

China-based EV company NIO Inc. NIO is slated to release first-quarter 2025 results on June 3, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a loss of 22 cents a share on revenues of $1.71 billion.

BMY slides 20.7% in 3 months despite strong Q1 and raised outlook, as generic pressure and pipeline setbacks weigh on investor sentiment.

MSEX makes a strong case for investment, given its growth prospects, better debt management and capability to increase shareholders' value.

XOM is set to sell its French refining assets to North Atlantic, retaining Esso retail and specialty operations. The deal is expected to be closed in Q4 2025.

Jim Cramer breaks down why he's keeping an eye on shares of Dollar Tree.

ASLE's share price drops amid solid solvency position, while AL sees steady revenue growth and strong return on equity despite higher debt levels.

Enterprise-software firm C3.ai shares are on the rise after slumping earlier this year on fears of an artificial-intelligence bubble, and ongoing losses.

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Schrdinger, Inc. ("Schrdinger, Inc.") (NASDAQ:SDGR) concerning possible violations of federal securities laws. Schrödinger issued a press release on May 20, 2025, "announcing that the company and Geoffrey Porges, MBBS.

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of UroGen Pharma Ltd. ("UroGen Pharma Ltd.

Nvidia continues to lead the AI revolution, despite a slowdown in China, according to Dan Ives of Wedbush Securities. He's on "Bloomberg Surveillance.

NBIS delivered stellar Q1 earnings with 385% YoY revenue growth and is on track for exponential topline expansion, reinforcing my bullish stance. Aggressive global data center expansion and strong Nvidia partnership position NBIS to capture accelerating AI adoption across industries and geographies. My DCF analysis shows NBIS is massively undervalued, with huge upside potential even under conservative growth assumptions.

Investors cited declining sales, reputational damage and Musk's growing list of outside ventures -- including a now-concluded stint at DOGE.

HP Inc (NYSE:HPQ) shares fell more than 6% in early trade on Thursday after the technology company trimmed its full-year outlook, citing added costs due to US tariffs, and reported mixed earnings for the fiscal second quarter. The company now expects full-year earnings per share (EPS) in the range of $3 to $3.30, below the Street consensus of $3.50.

Amid extreme market volatility and ambiguity, the traditional stock picking method ??? sales growth?

To put the $160 billion in value Nvidia added Thursday, the entire company was worth just $144 billion at the end of 2019.

Nvidia Corporation delivered strong Q1 revenue growth and outperformed expectations, despite a significant gross margin hit from China export restrictions. Data Center and Gaming segments remain robust growth engines, with AI demand and new product launches driving results. Valuation is elevated but justified by Nvidia's market leadership, high earnings growth, and strong free cash flow generation.

Nvidia CEO Jensen Huang is preparing to offload a significant chunk of company stock—again.

Singapore, May 29, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today reaffirmed the strength of its underlying financial performance and strategic outlook, despite recent volatility in its share price.